<?xml version="1.0" encoding="ISO-8859-1" ?>
<rss version="2.0">
  <channel>
    <title><![CDATA[Noticias del Periódico Virtual]]></title>
    <link><![CDATA[Periódico Virtual]]></link>
    <description><![CDATA[Noticias varias]]></description>
    <language>es-es</language>
    <image>
      <url><![CDATA[]]></url>
      <title><![CDATA[Periódico Virtual]]></title>
      <link><![CDATA[Periódico Virtual]]></link>
    </image>
    <item>
      <title><![CDATA[Seasonal Allergies Expert]]></title>
      <link><![CDATA[dontgonuts.co.uk/index.php?option=com_periodicos&task=verNoticia&IDNoticia=7]]></link><guid isPermaLink="true"><![CDATA[dontgonuts.co.uk/index.php?option=com_periodicos&task=verNoticia&IDNoticia=7]]></guid><description><![CDATA[Seasonal allergies follow the growth cycle of plants. Beginning in early March, the common allergies come from tree pollen, and by late April or early May, grass begins to pollinate. These allergies last until July and then the next round begins with ragweed and other weeds start in August.    Allergy symptoms are often seen through your eyes, nose, and throat.]]></description>
      <pubDate><![CDATA[2009-02-28 11:00:00]]></pubDate>
    </item>
    <item>
      <title><![CDATA[Springtime Allergies: Is It Time For Allergy Shots?]]></title>
      <link><![CDATA[dontgonuts.co.uk/index.php?option=com_periodicos&task=verNoticia&IDNoticia=8]]></link><guid isPermaLink="true"><![CDATA[dontgonuts.co.uk/index.php?option=com_periodicos&task=verNoticia&IDNoticia=8]]></guid><description><![CDATA[Jennifer Derebery, M.D., physician at the House Clinic and leading expert on the treatment of allergies, believes there a several options available to people with significant symptoms before starting allergy shots.]]></description>
      <pubDate><![CDATA[2009-02-28 10:00:00]]></pubDate>
    </item>
    <item>
      <title><![CDATA[La Jolla Institute For Allergy And Immunology Signs Exclusive License Agreement With Medimmune On Major Asthma Discovery]]></title>
      <link><![CDATA[dontgonuts.co.uk/index.php?option=com_periodicos&task=verNoticia&IDNoticia=5]]></link><guid isPermaLink="true"><![CDATA[dontgonuts.co.uk/index.php?option=com_periodicos&task=verNoticia&IDNoticia=5]]></guid><description><![CDATA[A major asthma discovery by a researcher at the La Jolla Institute for Allergy and Immunology has been licensed by MedImmune, a leading innovation-focused biotechnology company and wholly owned subsidiary of AstraZeneca PLC.  MedImmune licensed the discovery to explore its use in the development of a potential biologics drug for treating asthma.]]></description>
      <pubDate><![CDATA[2009-02-26 11:00:00]]></pubDate>
    </item>
    <item>
      <title><![CDATA[Frequency Of T-cells Determines Severity Of Asthma, Study Finds]]></title>
      <link><![CDATA[dontgonuts.co.uk/index.php?option=com_periodicos&task=verNoticia&IDNoticia=6]]></link><guid isPermaLink="true"><![CDATA[dontgonuts.co.uk/index.php?option=com_periodicos&task=verNoticia&IDNoticia=6]]></guid><description><![CDATA[According to a new study, the frequency of regulatory T-cells (Treg) correlates to the severity of inflammation in allergic asthma, suggesting that Treg may play an important role in asthma pathogenesis.     A study in Respirology, published by Wiley-Blackwell, used mouse models and peripheral blood mononuclear cells from subjects with allergic asthma to assess the association of the Treg cells with asthma phenotypes.]]></description>
      <pubDate><![CDATA[2009-02-26 10:00:00]]></pubDate>
    </item>
    <item>
      <title><![CDATA[Grazax(R), Grass Pollen Allergen Tablet, Launched For Use In Children]]></title>
      <link><![CDATA[dontgonuts.co.uk/index.php?option=com_periodicos&task=verNoticia&IDNoticia=2]]></link><guid isPermaLink="true"><![CDATA[dontgonuts.co.uk/index.php?option=com_periodicos&task=verNoticia&IDNoticia=2]]></guid><description><![CDATA[ALK-AbellÃƒÂ³ Ltd announced today that GrazaxÂ®, grass-pollen allergen tablet, is now available for use in children and adolescents aged 5 to 17.   Grazax is the only non-injection immunotherapy licensed to treat children suffering from severe grass pollen induced seasonal allergic rhinitis and conjunctivitis or severe hay fever1. In addition, it is the first immunotherapy tablet to address the underlying cause of grass pollen allergy2,3.]]></description>
      <pubDate><![CDATA[2009-02-24 15:00:00]]></pubDate>
    </item>
    <item>
      <title><![CDATA[Babies Born During High Pollen And Mold Seasons Have Greater Odds Of Wheezing By Age 2]]></title>
      <link><![CDATA[dontgonuts.co.uk/index.php?option=com_periodicos&task=verNoticia&IDNoticia=3]]></link><guid isPermaLink="true"><![CDATA[dontgonuts.co.uk/index.php?option=com_periodicos&task=verNoticia&IDNoticia=3]]></guid><description><![CDATA[Newborns whose first few months of life coincide with high pollen and mold seasons are at increased risk of developing early symptoms of asthma, suggests a new study led by researchers at the University of California, Berkeley.]]></description>
      <pubDate><![CDATA[2009-02-24 14:00:00]]></pubDate>
    </item>
    <item>
      <title><![CDATA[Grass-pollen Tablet Launched To Treat Severe Hay Fever In Children]]></title>
      <link><![CDATA[dontgonuts.co.uk/index.php?option=com_periodicos&task=verNoticia&IDNoticia=4]]></link><guid isPermaLink="true"><![CDATA[dontgonuts.co.uk/index.php?option=com_periodicos&task=verNoticia&IDNoticia=4]]></guid><description><![CDATA[GrazaxÂ®, a grass-pollen allergen tablet, has been launched for use in children and adolescents aged 5 to 17 by Allergy Company ALK-AbellÃƒÂ³.  Grazax is the only non-injection immunotherapy licensed to treat children suffering from severe hay fever caused by grass pollen allergy.     Grazax has been available for use in adults in the UK since January 2007.  It"s a once daily, fast-melting tablet which is placed under the tongue.]]></description>
      <pubDate><![CDATA[2009-02-24 13:00:00]]></pubDate>
    </item>
    <item>
      <title><![CDATA[Wide Range Of Human Health And Environment Topical Sessions To Be Featured In Toxicology Program]]></title>
      <link><![CDATA[dontgonuts.co.uk/index.php?option=com_periodicos&task=verNoticia&IDNoticia=1]]></link><guid isPermaLink="true"><![CDATA[dontgonuts.co.uk/index.php?option=com_periodicos&task=verNoticia&IDNoticia=1]]></guid><description><![CDATA[Nearly 6,500 toxicologists from around the world will be gathering in Baltimore, Maryland March 15-19, to create an unparalleled venue for discussion of a number of health and environmental topics of concern to the public. The Society of Toxicology"s 2009 Annual Meeting and ToxExpo brings together thousands of scientists from universities, government, and industry to showcase a year"s worth of achievements in research and education.]]></description>
      <pubDate><![CDATA[2009-02-23 09:00:00]]></pubDate>
    </item>
  </channel>
</rss>